Inactive

Entered June 1, 2020 - Modification extends the due date from June 5, 2020 to June 9, 2020, 10:00 a.m. E.T. Entered May 27, 2020 - Modification provides answers to questions from potential offerors, e... Entered June 1, 2020 - Modification extends the due date from June 5, 2020 to June 9, 2020, 10:00 a.m. E.T. Entered May 27, 2020 - Modification provides answers to questions from potential offerors, extends the due date from May 31, 2020 to June 5, 2020, 10:00 a.m., and the amended combined synopsis/solicitation document is attached. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, “Streamlined Procedures for Evaluation and Solicitation for Commercial Items,” as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested, and a written solicitation document will not be issued. The solicitation is being issued using simplified acquisition procedures under the authority of FAR 13.5 Test Program for Certain Commercial Items. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2020-06, Effective 05-06-2020. The associated North American Industrial Classification System (NAICS) code for this procurement is 511210, Software Publishing, with a small business size standard of $38.5 million. This acquisition is full and open to all business sizes. Responses are due by 10:00 a.m., June 9, 2020. Questions may be submitted by email to the Contract Specialist (Lisa.Schaupp@nih.gov) through May 27, 2020 by 9:00 a.m. E.T. Answers will be posted by 5:00 p.m. E.T. May 27, 2020. The National Institute of Health, Office of Purchasing and Contracts, is seeking to acquire an automated high density pharmacy storage and IV workflow solution that interfaces with the Automated Dispensing Cabinets (ADCs) and pharmacy inventory management systems in order to increase safety and efficiency. The dispensing software will also communicate with the pharmacy information system to allow first-dose and cart-fill/ADC dispensing requests to be received and then processed and filled by technicians. The solution will provide real time tracking of current inventory and medications to order. Please see the Combined Synopsis/Solicitation attached for details of the requirement.

Inactive

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health, Clinical Center (CC) inten... This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health, Clinical Center (CC) intends to award a Fixed Price Purchase Order to Omnicell Inc., 590 E. Middlefield Road, Mountainview, CA 94043-4008, on a sole source basis to procure the XR2 High Density Storage System, High Speed packager, IV Workflow station system and service/installation requirements for the permanent IVAU Room in the Pharmacy Department with delivery and installation as necessary to fulfill the current need. The Government intends to include a base Period of 12 months and four (4) 12 month Option Periods in the Purchase Order. Purchase of Omnicell’s equipment and software for the IVAU Room will allow integration with current Omnicell software and equipment throughout the NIH Clinical Center for crucial storage, accurate medication filling, and recording capability for patient care and safety. This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12 in conjunction with the policies and procedures for the competition requirements in FAR Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Lisa Schaupp, Contract Specialist, Lisa.Schaupp@nih.gov, by the due date and time marked in this notice.

Inactive

The National Institutes of Health (“NIH”), Clinical Center is conducting a market survey/sources sought notice to determine whether there is a reasonable expectation of a responsible/capable offeror t... The National Institutes of Health (“NIH”), Clinical Center is conducting a market survey/sources sought notice to determine whether there is a reasonable expectation of a responsible/capable offeror to provide a Research Hospital High Density Automated Pharmacy Storage and Inventory Solution with, at least, the characteristics listed below. Accordingly, NIH is hoping that there exists a reasonable expectation of at least two responsible/capable offerors in order for NIH to compete the requirement. Additionally, NIH is attempting to ascertain if there exists a reasonable expectation of at least two responsible/capable small business offerors in order for NIH to compete the requirement as a small business set aside. Accordingly, NIH is seeking capability statements as to the attached SOW from other-than-small businesses, small businesses, veteran-owned small businesses, service disabled veteran-owned small businesses, HUBZONE small businesses, small businesses under the 8(a) program, and/or businesses under the GSA Schedule capable of providing a system with the following performance characteristics. The Pharmacy Storage and Inventory Management System must be capable of providing the following. 1. MINIMUM REQUIREMENTS 1.1 The Contractor shall provide a non-developmental automated robotic Storage System capable of storing high density medications that will operate as a single integrated solution. The solution shall use a commercial off the shelf software and hardware component that are configurable to the NIH Clinical Center workflow. The solution must have been demonstrated and proven to be in use at another inpatient pharmacy hospital setting. 1.2 The contractor shall provide a dedicated on-site support staff member that will provide service, troubleshooting and training for up to a year post implementation. 1.3 The solution shall fit into the pharmacy. Any changes needed/required to accommodate the vendors quoted solution such as the relocation of current fixed shelving/furniture in existing space or addition of dedicated power lines, must be quoted as part of vendors solution and will be considered normal installation. Vendors are responsible for verifying all dimensions and other design features necessary for operation and installation of their quoted solution. 1.4 The solution shall be a fully automated dispensing and inventory management system utilizing a robotic arm for picking and storage. 1.5 The hardware component shall be capable of withstanding a 60 second loss of utility power with no loss of data and no manual intervention to recover. 1.6 The automated storage system shall be able to store at minimum 60,000 line items of non-IV formulary. 1.7 The system shall be able to dispense medications for verified patient orders including scheduled, STAT/Now and first dose orders. 1.8 The system must include a barcode-driven checking/verification utility that can be used by pharmacists (or technicians tech-check-tech) to verify accuracy of orders before leaving the pharmacy. 1.9 The pharmacy automation solution shall use automatic wireless barcode scanning as a means of medication and patient validation throughout the stocking, filling, dispensing and returning to stock process. 1.10 The solution shall support both non-IV and non-narcotic formulary in variety of form factors such as oral solids in unit dose (manufacturer-packaged blister style or pouch/repackaged), oral solid cards, vials (1-100 mL), liquid dose cups, syringes/capujects, packets, patches, boxes, and IV bags up to 150 mL). 1.11 The solution shall be capable of automatically bagging patient specific medications by placing dispensed medications into sealed bags printed with patient or cabinet information with barcode. 1.12 The system shall be capable of ensuring that earliest expiring medications are dispensed first. 1.13 The system shall have an active storage management system for maximum efficiency and throughput. 1.14 The pharmacy automation solution shall interface with the Allscripts EHR, Omnicell ADCs, inventory Management System and other commercial off-the-shelf (COTS) pharmacy systems. Loss of the interface with EHR shall not impede the system from continuing to fill orders until all orders that have already been transferred are completed. 1.15 When dispensing medication from the storage unit, the pharmacy automated storage solution shall 1.15.1 Be capable of using and displaying multiple unique patient identifiers. 1.15.2 Print a label to be affixed to the medications to be restocked in the ADC. 1.15.3 Use software to fill products not in the automated storage, including, but not limited to fluid bags and irregular dosage forms. 1.15.4 Automatically notify user if the automation does not have enough quantity to fulfill the entire order and provide the user option to replenish the automation or divert the order to manual fulfillment based on defined par, max, min and critical levels. 1.16 Upon receiving information from CRIS or ADC, the pharmacy automation System shall: 1.16.1 Be capable of using and displaying multiple unique patient identifiers. 1.16.2 Be capable of updating patient location and handle patient merges automatically in real time. 1.16.3 Process the information received and retrieve the medication stored. 1.16.4 Alert pharmacy personnel of stat vs routine orders. 1.16.5 Print medication labels that can be used for restocking. 1.17 For manually fulfilled orders, the system shall require user to scan the medication package before providing the label. 1.18 The system shall allow users to flag an order when there is insufficient quantity to fulfill the entire ordered quantity. 1.19 The solution shall have the ability to recognize brand name NDC (National Drug Code) and generic NDC items found on the FDA approved NDC directory. 1.20 The inventory management software shall provide “Real-Time” inventory tracking of pharmaceutical products. 1.21 The system shall be capable of providing historical reference of all items in the event of a recall. 1.22 The inventory management software shall support manual or automated cycle counts. 1.23 The system shall be capable of ordering via the web for remote locations. See Attached Statement of Work (DRAFT) for more details. THIS MARKET SURVEY/SOURCES SOUGHT ANNOUNCEMENT IS NOT A REQUEST FOR PROPOSALS, AND THE GOVERNMENT IS NOT COMMITTED TO AWARD A CONTRACT PURSUANT TO THIS ANNOUNCEMENT. CONSEQUENTLY, DO NOT SEND A PROPOSAL IN RESPONSE TO THIS NOTICE. THE APPROPRIATE RESPONSE IS A CAPABILITY STATEMENT. ALTHOUGH A RESPONDENT CAN RESPOND WITH WHATEVER INFORMATION THE RESPONDENT SEES FIT, THE IDEAL CAPABILITY STATEMENT SPECIFICALLY ADDRESSES THE REQUIREMENTS IN THE SOW AND THE REQUESTS FOR INFORMATION BELOW, AND IS NOT A GENERIC SALES BROCHURE OR MARKETING HANDOUT. FURTHER, THE GOVERNMENT REQUESTS, BUT DOES NOT MANDATE, THAT THE CAPABILITY STATEMENT IS LIMITED TO NO MORE THAN TEN PAGES. ANY PROPRIETARY INFORMATION IN THE SUBMITTED CAPABILITY STATEMENT SHOULD BE CLEARLY MARKED AS SUCH. The information obtained from this market research is for Government planning purposes only, and will assist the Government in planning its acquisition strategy. This is strictly market research, and the Government is not opening a question and answer period concerning this market research. Further, the Government will not pay for any costs incurred in the preparation of information in response to this market survey. In addition to addressing the requirements listed above, the Government requests that your capability statement address the following requests for information, if relevant. Please provide the full company/entity name, address including points of contact (phone number and e-mail address), DUNS numbers, and type/size of the company/entity by NAICS code. If your company/entity is a dealer or service-provider, and not a manufacturer of the end items/products contemplated by the SOW, please identify your company as such and identify the end item/product manufacturers that you would be obtaining goods from in order to perform the contract, and where the manufacturers are geographically located. According to the small business limitations on subcontracting standard provided by the amended Small Business Act at 15 U.S.C. § 657s, the requirement for a small business supplier is that the small business prime contractor “may not expend on subcontractors more than 50 percent of the amount, less the cost of materials, paid to the concern under the contract . . . .” 15 U.S.C. § 657s(a)(2). However, “[c]ontract amounts expended by a covered small business concern on a subcontractor that is a similarly situated entity [(i.e., another small/small disadvantaged business of the same type)] shall not be considered subcontracted for purposes of determining whether the covered small business concern has violated [limitations on subcontracting.]” 15 U.S.C. § 657s(b). If you are a small business, please address your ability to adhere to limitations on subcontracting at 15 U.S.C. § 657s. To ascertain if you are a small business, use the size standard provided by NAICS Code 511210 (Software Publishers), with a size standard of no more than $41.5 million. As part of this, if you are a small business that is a dealer/service-provider and not a manufacturer, please so state, and address whether you meet the following requirements from 13 C.F.R. § 121.406(b). Specifically, your company/entity: (1) Does not exceed 500 employees (notice that the employee standard under the non-manufacturer rule is more restrictive than for NAICS Code 511210); (2) Is primarily engaged in the retail or wholesale trade and normally sells the type of item being supplied; (3) Takes ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice; and (4) Will supply the end item of a small business manufacturer, processor, or producer made in the United States. NIH must receive written capability statements no later than January 3, 2020 at 9:00 a.m. Eastern Time. E-mail the written capability statement to Lisa Schaupp, the Contract Specialist, at the e-mail address Lisa.Schaupp@nih.gov.NIH Respondents will NOT be notified as to the results of the Government’s market research.